Literature DB >> 15358228

Dual action of adiponectin on insulin secretion in insulin-resistant mice.

Maria Sörhede Winzell1, Rubén Nogueiras, Carlos Dieguez, Bo Ahrén.   

Abstract

Adiponectin is secreted by adipocytes and has been implicated as a mediator of insulin sensitivity. In this study, the acute effects of adiponectin on islets isolated from normal or diet-induced insulin resistant mice were examined. In normal islets, adiponectin (5 microg/ml) had no significant effect on insulin secretion. In contrast, in islets from mice rendered insulin resistant by high-fat feeding, adiponectin inhibited insulin secretion at 2.8 mM (P < 0.01) but augmented insulin secretion at 16.7 mM glucose (P < 0.05). The augmentation of glucose-stimulated insulin secretion by adiponectin was accompanied by increased glucose oxidation (P < 0.005), but without any significant effect on palmitate oxidation or the islet ATP/ADP ratio. Furthermore, RT-PCR revealed the expression of the adiponectin receptor AdipoR1 mRNA in mouse islets, however, with no difference in the degree of expression level between the two feeding groups. The results thus uncover a potential dual role for adiponectin to modify insulin secretion in insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358228     DOI: 10.1016/j.bbrc.2004.06.130

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

Review 1.  Adipocytes as regulators of energy balance and glucose homeostasis.

Authors:  Evan D Rosen; Bruce M Spiegelman
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

2.  Association of sequence variations in the gene encoding adiponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish Diabetes Prevention Study.

Authors:  N Siitonen; L Pulkkinen; U Mager; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; J Tuomilehto; M Laakso; M Uusitupa
Journal:  Diabetologia       Date:  2006-05-25       Impact factor: 10.122

3.  Nutrigenomics, beta-cell function and type 2 diabetes.

Authors:  R Nino-Fong; Tm Collins; Cb Chan
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

Review 4.  Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk.

Authors:  Jennifer H Stern; Joseph M Rutkowski; Philipp E Scherer
Journal:  Cell Metab       Date:  2016-05-10       Impact factor: 27.287

5.  Adipsin is an adipokine that improves β cell function in diabetes.

Authors:  James C Lo; Sanda Ljubicic; Barbara Leibiger; Matthias Kern; Ingo B Leibiger; Tilo Moede; Molly E Kelly; Diti Chatterjee Bhowmick; Incoronata Murano; Paul Cohen; Alexander S Banks; Melin J Khandekar; Arne Dietrich; Jeffrey S Flier; Saverio Cinti; Matthias Blüher; Nika N Danial; Per-Olof Berggren; Bruce M Spiegelman
Journal:  Cell       Date:  2014-07-03       Impact factor: 41.582

Review 6.  The control of insulin secretion by adipokines: current evidence for adipocyte-beta cell endocrine signalling in metabolic homeostasis.

Authors:  James Cantley
Journal:  Mamm Genome       Date:  2014-08-22       Impact factor: 2.957

7.  Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications.

Authors:  R Retnakaran; A J G Hanley; N Raif; C R Hirning; P W Connelly; M Sermer; S E Kahn; B Zinman
Journal:  Diabetologia       Date:  2005-03-19       Impact factor: 10.122

Review 8.  Adiponectin: mechanistic insights and clinical implications.

Authors:  A T Turer; P E Scherer
Journal:  Diabetologia       Date:  2012-06-12       Impact factor: 10.122

9.  Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice.

Authors:  Galyna Bryzgalova; Lovisa Lundholm; Neil Portwood; Jan-Ake Gustafsson; Akhtar Khan; Suad Efendic; Karin Dahlman-Wright
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-12       Impact factor: 4.310

10.  Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration.

Authors:  M Okamoto; M Ohara-Imaizumi; N Kubota; S Hashimoto; K Eto; T Kanno; T Kubota; M Wakui; R Nagai; M Noda; S Nagamatsu; T Kadowaki
Journal:  Diabetologia       Date:  2008-03-28       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.